37. Lodstein JL, Dana SE and Brown MS. Esterification of low density lipoprotein 
cholesterol in human fibroblasts and its absence in homozygous familial 
hypercholesterolemia. Proc Natl Acad Sci USA, Nov 1974;71(11):4288-92. 
38. Glickman RM and Sabesin SM. Lipoprotein metabolism. In The Liver: Biology and 
Pathophysiology (Aria IM, Jakoby WB, Popper H, Schachter D and Shafritz DA, eds), 
2nd edit., 1988, pp. 331-354, Raven Press Ltd, New York. 
39. Turley SD and Dietschy JM. The metabolism and excretion of cholesterol by the liver. 
In The Liver; Biology and Pathophysiology (Aria IM, Jakoby WB, Popper H, Schachter D 
and Shafritz DA, eds), 2nd edit., 1988, pp. 617-641, Raven Press Ltd, New York. 
40. Robins SJ, Fasulo JM, Collins MA and Patton GM. Evidence for separate pathways of 
transport of newly synthesized and preformed cholesterol into bile. J Biol Chem, Jun 
10 1 985;260(1 1 ):651 1 -3. 
41 . Sprecher DL, Hoeg JM, Schaefer EJ, Zech LA, Gregg RE, Lakatos E and Brewer HB, Jr. 
The association of LDL receptor activity, LDL cholesterol level, and clinical course in 
homozygous familial hypercholesterolemia. Metabolism, Mar 1985;34(3):294-99. 
42. Goldstein JL and Brown MS. The LDL receptor defect in familial hypercholesterolemia. 
Implications for pathogenesis and therapy. Med Clin North Am, Mar 1982;66(2):335- 
62. 
43. . Sprecher DL, Schaefer EJ, Kent KM, Gregg RE, Zech LA, Hoeg JM, McManus B, Roberts 
WC and Brewer HB, Jr. Cardiovascular features of homozygous familial 
hypercholesterolemia analysis of 16 patients. Am J Cardiol, July 1 1984;54(1):20- 
30. 
44. Haitas B, Baker SG, Meyer TE, Joffe Bl and Seftel HC. Natural history and cardiac 
manifestations of homozygous familial hypercholesterolemia. Q J Med, Jul 
1990;76(279):731-40. 
45. Khachadurian AK and Uthman SM. Experiences with the homozygous cases of familial 
hypercholesterolemia. A report of 52 patients. Nutr Metab, 1973;1 5(1 ):1 32-40. 
46. Mabuchi H, Tatami R, Haba T, Ueda K, Ueda R, Kametani T, Itoh S, Koizumi J, Oota M, 
Miyamoto S, Takeda R and Takeshita H. Homozygous familial hypercholesterolemia in 
Japan. Am J Med, Aug 1978;65(2):290-97. 
47. Mabuchi H, Koizumi H, Shimizu M and Takeda R. Development of coronary heart disease 
in familial hypercholesterolemia. Circulation, Feb 1989;79(2):225-32. 
48. Moorjani S, Roy M, Gagne C, Davignon J, Brun D, Toussaint M, Lambert M, Campeau L, 
Blaichman S. and Lupien P. Homozygous familial hypercholesterolemia among French 
Canadians in Quebec Province. Arteriosclerosis, Mar-Apr 1 989;9(2):21 1 -1 6. 
49. Lehrman MA, Schneider WJ, Brown MS, David CG, Elhammer A, Russell DW and 
Goldstein JL. The Lebanese allele at the low density lipoprotein receptor that is retained 
in endoplasmic reticulum. J Biol Chem, Jan 5 1 987 ;262(1 ) :401 -1 0. 
50. Leitersdorf E., Tobin EJ, Davignon J and Hobbs HH. Common low-density lipoprotein 
receptor mutations in the French Canadian population. J Clin Invest, Apr 
1 990;85(4):1 014-23. 
51 . Goldstein JL and Brown MS. Progress in understanding the LDL receptor and HMG-CoA 
reductase, two membrane proteins that regulate the plasma cholesterol. J Lipid Res, Dec 
15 1 9 84 ;25 ( 1 3) :1 450-61 . 
52. Sudhof TC, Russell DW, Brown MS and Goldstein JL. 42 bp element from LDL receptor 
gene confers end-product repression by sterols when inserted into viral TK promoter. 
Cell, Mar 27 1987;48(6):1 061 -69. 
53. Miyanohara A, Sharkey MF, Witztum JL, Steinberg D and Freidmann T. Efficient 
expression of retroviral vector-transduced human low density lipoprotein (LDL) 
receptor-deficient rabbit fibroblasts in vitro. Proc Natl Acad Sci USA, Sep 
1 988 ;85( 1 7) :6538-42. 
[198] 
Recombinant DNA Research, Volume 15 
